Trabecular Bone Score: a paradigm shift in osteoporosis assessment and management
Download the white paper to:
- Learn more about the scientific underpinnings, clinical utility, and the value of TBS in improving osteoporosis management.
- Gain understanding about TBS’s integral role in a paradigm shift toward more complete fracture risk assessments.
- Understand how TBS can be seamlessly integrated within existing clinical workflows.
Enhancing osteoporosis risk assessment with TBS
Osteoporosis is a skeletal disease marked by reduced bone mass and deteriorated bone structure, critical for preventing fractures. Traditional bone mineral density (BMD) assessments, focusing on a T-score of -2.5 or lower, identify those at risk of fractures due to low bone mass. However, many fractures occur in people with non-osteoporotic T-scores, indicating a need for a more comprehensive risk assessment that includes bone microarchitecture.
The Trabecular Bone Score (TBS) addresses this need by analyzing DXA scans to evaluate bone microarchitecture. TBS correlates well with bone strength, enhancing fracture risk assessment when combined with BMD T-scores. Clinically, TBS improves fracture risk predictions and therapeutic decisions, either by refining existing metrics or as a standalone measure. This white paper explores the science, clinical applications, and benefits of TBS in advancing osteoporosis management.
